NCT04597086
- Conditions
- Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Refractory Leukemia
Explore clinical trials studying Refractory Leukemia. Study availability and eligibility vary by location and protocol.
14 public trials
8 recruiting studies
Refractory Leukemia trial results
NCT00880269
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University of Chicago Medical Center Dept. of U. of Chicago Hosp(3) Chicago, Illinois, United States
- Nebraska Methodist Hospital Nebraska Methodist Hospital(2) Omaha, Nebraska, United States
- North Shore University Hospital North Shore Univ Manhasset, New York, United States
- Memorial Sloan Kettering Cancer Center Dept. of MSKCC (2) New York, United States
Active, Not Recruiting
Tegavivint for the Treatment of Relapsed or Refractory Leukemia
NCT04874480
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
NCT04282811
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Aou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione Cona, Ferrara, Italy
- Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
- Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
- Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo Cagliari, Italy